atrial fibrillation fibrillation
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients who have undergone minimal invasive surgical ablation for paroxysmal or persistent atrial fibrillation between 2008 and 2010 in the Academic Medical Center.
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Freedom of any recurrence of atrial fibrillation, atrial flutter or atrial tachycardia, documented on ECG or 24-hour Holter within five years after the procedure without the use of antiarrhythmic drugs. -Sinus rhythm on electrocardiogram at follow up visit five years or more ofter the procedure. -Use of antiarrhythmic drugs at follow up visit. | — |
Secondary
| Measure | Time frame |
|---|---|
| -Functional status measured by the SF-36 Quality of Life questionnaire at 60 months follow up. -The occurrence of any procedure related complications and the occurrence of other clinical events during 60 months follow up. -Major adverse cardiac events (MACE) during 60 months or more follow up. | — |
Countries
Netherlands
Outcome results
None listed